Campo DC | Valor | Idioma |
dc.creator | Silva, Mayara Sousa | - |
dc.date.accessioned | 2023-11-13T08:08:49Z | - |
dc.date.available | 2023-11-13T08:08:49Z | - |
dc.date.issued | 2020-08-14 | - |
dc.identifier.citation | SILVA, Mayara Souza. Qualidade de vida de asmáticos graves submetidos à intervenção de telemedicina. 2019. 77 f. Dissertação (mestrado) - Universidade Federal da Bahia, Escola de Enfermagem, Pós-graduação em Enfermagem e Saúde, Salvador, 2019. | pt_BR |
dc.identifier.uri | https://repositorio.ufba.br/handle/ri/38419 | - |
dc.description.abstract | Asthma is one of the most prevalent chronic diseases globally, affecting approximately 339
million people worldwide. Additionally, it ranks 28th among the main causes of disability due
to illness and 16th among the main causes of years lived with disability. The absence of asthma
control is the main risk factor related to death, the main causes of which are respiratory failure
and asthma attacks. In general, the reduction in the quality of life of asthmatics is proportional
to the degree of activity of the disease, and asthma is a disease that can cause considerable
physical, emotional and social restrictions to asthmatics, when not controlled. This is a quasi-
experimental study carried out in a reference center for the treatment of severe asthma, where
a convenience sample of 67 individuals in the intervention group was analyzed. For the
sociodemographic and clinical characterization in V0 and V1, the nonparametric variables,
verified by means of the Kolmogorov-Smirnov test, with statistically significant results with p
<0.05. In the comparison between V0 and VI, the quality of life scores were maintained (V0:
QOL = 4.53 [1.53 - 7.00] vs. V1: QOL = 4.20 [1.93 - 7.00], P = 0.41). The highest scores were
in the symptom domains (V0: QOL = Md: 5.20 [1.00 - 7.00] vs. V1: QL = Md: 4.80 [1.20 -
7.00], P = 0, 75) and the lowest scores in the environmental stimulus domain (V0: QV = Md:
3.66 [1.00 - 7.00] vs. V1: QV = Md: 3.33 [1.00 - 7.00], P = 0.77). In the studies carried out, we
identified that the severe asthmatics participants had a moderate loss of quality of life, with
maintenance after the intervention. The study contributed mainly to rethink how the
telemedicine tool can be an alternative for improving asthma management for the population
and health professionals. | pt_BR |
dc.language | por | pt_BR |
dc.publisher | Universidade Federal da Bahia | pt_BR |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Brazil | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/br/ | * |
dc.subject | Asma | pt_BR |
dc.subject | Qualidade de vida | pt_BR |
dc.subject | Telemedicina | pt_BR |
dc.subject.other | Asthma | pt_BR |
dc.subject.other | Quality of life | pt_BR |
dc.subject.other | Telemedicine | pt_BR |
dc.title | Qualidade de vida de asmáticos graves submetidos à intervenção de telemedicina | pt_BR |
dc.title.alternative | Quality of life of severe asthmatics undergoing telemedicine intervention | pt_BR |
dc.title.alternative | Calidad de vida de asmáticos graves sometidos a intervención de telemedicina | pt_BR |
dc.type | Dissertação | pt_BR |
dc.publisher.program | Programa de Pós-Graduação em Enfermagem (PPGENF) | pt_BR |
dc.publisher.initials | UFBA | pt_BR |
dc.publisher.country | Brasil | pt_BR |
dc.subject.cnpq | CNPQ::CIENCIAS DA SAUDE::ENFERMAGEM::ENFERMAGEM DE SAUDE PUBLICA | pt_BR |
dc.contributor.advisor1 | Machado, Carolina Souza | - |
dc.contributor.advisor1ID | https://orcid.org/0000-0001-7328-9608 | pt_BR |
dc.contributor.advisor1Lattes | http://lattes.cnpq.br/6922770216991526 | pt_BR |
dc.contributor.advisor-co1 | Coelho, Ana Carla Carvalho | - |
dc.contributor.advisor-co1ID | https://orcid.org/0000-0003-1792-1319 | pt_BR |
dc.contributor.advisor-co1Lattes | http://lattes.cnpq.br/7698839867078154 | pt_BR |
dc.contributor.referee1 | Coelho, Ana Carla Carvalho | - |
dc.contributor.referee1ID | https://orcid.org/0000-0003-1792-1319 | pt_BR |
dc.contributor.referee1Lattes | http://lattes.cnpq.br/7698839867078154 | pt_BR |
dc.contributor.referee2 | Martins, Ridalva Dias Félix | - |
dc.contributor.referee2ID | https://orcid.org/0000-0003-0295-9998 | pt_BR |
dc.contributor.referee2Lattes | http://lattes.cnpq.br/2227496631687090 | pt_BR |
dc.contributor.referee3 | Sampaio, Elieusa e Silva | - |
dc.contributor.referee3ID | https://orcid.org/0000-0003-1702-7296 | pt_BR |
dc.contributor.referee3Lattes | http://lattes.cnpq.br/8043879827663481 | pt_BR |
dc.contributor.referee4 | Fernandes, Andréia Guedes Oliva | - |
dc.contributor.referee4ID | https://orcid.org/0000-0001-5584-5658 | pt_BR |
dc.contributor.referee4Lattes | http://lattes.cnpq.br/9522936068536468 | pt_BR |
dc.creator.ID | https://orcid.org/0000-0002-5130-3349 | pt_BR |
dc.creator.Lattes | http://lattes.cnpq.br/6950944762601878 | pt_BR |
dc.description.resumo | A asma é uma das doenças crônicas mais prevalentes globalmente acometendo cerca de 339
milhões de pessoas em todo o mundo. Adicionalmente, ocupa a 28a posição entre as principais
causas de carga da doença e a 16a entre as principais causas de anos vividos com incapacidade.
A ausência do controle da asma é o principal fator de risco relacionado ao óbito, cujas principais
causas são insuficiência respiratória e crise asmática. De maneira geral, a redução na qualidade
de vida dos asmáticos é proporcional ao grau de atividade da doença, sendo a asma uma doença
que pode causar consideráveis restrições físicas, emocionais e sociais aos asmáticos, quando
não controlada. Trata-se de um estudo quase-experimental realizado em um centro de referência
para tratamento da asma grave, onde foi analisada uma amostra por conveniência com 67
indivíduos no grupo intervenção. Para a caracterização sociodemográfica e clínica em V0 e V1,
as variáveis não paramétricas foram verificadas por meio do teste Kolmogorov-Smirnov, sendo
considerados estatisticamente significantes resultados com p< 0,05. Na comparação entre V0 e
VI os escores de qualidade de vida se mantiveram (V0: QV= 4,53 [1,53 - 7,00] vs. V1: QV=
4,20 [1,93 - 7,00], P=0,41). Os maiores escores foram nos domínios sintomas (V0: QV= Md:
5,20 [1,00 - 7,00] vs. V1: QV= Md: 4,80 [1,20 - 7,00], P=0,75) e os menores escores no domínio
estímulos do ambiente (V0: QV= Md: 3,66 [1,00 - 7,00] vs. V1: QV= Md: 3,33 [1,00 - 7,00],
P=0,77). Nos estudos realizados identificamos que os asmáticos graves participantes
apresentavam prejuízo moderado na qualidade de vida, com manutenção após a intervenção. O
estudo contribuiu principalmente para repensar como a ferramenta da telemedicina pode ser
uma alternativa na melhoria do manejo da asma para a população e os profissionais de saúde. | pt_BR |
dc.publisher.department | Escola de Enfermagem | pt_BR |
dc.relation.references | 1. Pérez-Manchón D. Telemedicina, una red social médica de ayuda humanitaria entre
España y Camerún. Gac Sanit [Internet]. 2015 Feb; 29 (1): 59-61. Disponible en:
http://www.gacetasanitaria.org/es-linkresolver-telemedicina-una-red-social-medica-
S021391111400209X
2. Mariani AW, Pêgo-Fernandes PM. Telemedicine: a technological revolution. Sao Paulo
Med. J. [Internet]. 2012; 130 (5): 277-278. Available from:
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-
31802012000500001&lng=en.
3. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, Boulet LP. Global
asthma prevalence in adults: findings from the cross-sectional world health survey.
BMC Public Health. 2012 Mar 19; 12:204. doi: 10.1186/1471-2458-12-204. Available
from: https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-12-
204
4. The Global Asthma Report 2018. Auckland, New Zealand: Global Asthma Network,
2018.
5. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention,
2018. Available from: www.ginasthma.org.
6. Koufopoulos JT, Conner MT, Gardner PH, Kellar I. A Web-Based and Mobile Health Social
Support Intervention to Promote Adherence to Inhaled Asthma Medications:
Randomized Controlled Trial. J Med Internet Res. 2016 Jun 13;18(6):e122. doi:
10.2196/jmir.4963. Available from: https://www.jmir.org/2016/6/e122/ 7. Licskai C, Sands TW, Ferrone M. Development and pilot testing of a mobile health
solution for asthma self-management: asthma action plan smartphone application pilot
study. Can Respir J. 2013 Jul-Aug; 20(4): 301-6. Available from:
https://www.hindawi.com/journals/crj/2013/906710/abs/
8. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items
for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009 Jul
21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097. Epub 2009 Jul 21. Available
from:
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000097
9. van der Meer V, van den Hout WB, Bakker MJ, Rabe KF, Sterk PJ, Assendelft WJ, Kievit
J, Sont JK; SMASHING (Self-Management in Asthma Supported by Hospitals, ICT,
Nurses and General Practitioners) Study Group. Cost-effectiveness of Internet-based
self-management compared with usual care in asthma. PLoS One. 2011;6(11):e27108.
Available from:
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0027108 [included
in the review].
10. Pinnock H, Adlem L, Gaskin S, Harris J, Snellgrove C, Sheikh A. Accessibility, clinical
effectiveness, and practice costs of providing a telephone option for routine asthma
reviews: phase IV controlled implementation study. Br J Gen Pract. 2007
Sep;57(542):714-22. Available from: https://bjgp.org/content/57/542/714.long
[included in the review].
11. Pinnock H, McKenzie L, Price D, Sheikh A. Cost-effectiveness of telephone or surgery
asthma reviews: economic analysis of a randomised controlled trial. Br J Gen Pract.
2005 Feb;55(511):119-24. Available from: https://bjgp.org/content/55/511/119.long
[included in the review].
12. Ostojic V, Cvoriscec B, Ostojic SB, Reznikoff D, Stipic-Markovic A, Tudjman Z.
Improving asthma control through telemedicine: a study of short-message service.
Telemed J E Health. 2005 Feb;11(1):28-35. Available from:
https://www.liebertpub.com/doi/abs/10.1089/tmj.2005.11.28?url_ver=Z39.88-
2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed& [included in
the review].
13. Gruffydd-Jones K, Hollinghurst S, Ward S, Taylor G. Targeted routine asthma care in
general practice using telephone triage. Br J Gen Pract. 2005 Dec;55(521):918-23.
Available from: https://bjgp.org/content/55/521/918.long [included in the review].
14. World Health Organization. Preparing a health care work force for the 21st century: the
challenge of chronic conditions. Available from:
http://www.who.int/chp/knowledge/publications/workforce_report/en// 15. Taveira ZZ, Scherer MDA, Diehl EEl. Implantação da telessaúde na atenção à saúde
indígena no Brasil. Cad. Saúde Pública, Rio de Janeiro, 30(8):1793-1797, ago, 2014.
Available from: http://www.scielo.br/pdf/csp/v30n8/0102-311X-csp-30-8-1793.pdf
16. Dávalos ME, French MT, Burdick AE, Simmons SC. Economic evaluation of telemedicine:
review of the literature and research guidelines for benefit-cost analysis. Telemed J E
Health. 2009 Dec;15(10):933-48. Available from:
https://www.liebertpub.com/doi/abs/10.1089/tmj.2009.0067?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
17. Waller M, Stotler C. Telemedicine: a Primer. Curr Allergy Asthma Rep. 2018 Aug
25;18(10):54. Available from: https://link.springer.com/article/10.1007%2Fs11882-
018-0808-4
18. Waibel KH. Synchronous telehealth for outpatient allergy consultations: A 2-year
regional experience. Ann Allergy Asthma Immunol. 2016 Jun;116(6):571-575.e1.
Available from: https://www.annallergy.org/article/S1081-1206(16)30089-8/fulltext
19. Liu WT, Huang CD, Wang CH, Lee KY, Lin SM, Kuo HP. A mobile telephone-based
interactive self-care system improves asthma control. Eur Respir J. 2011
Feb;37(2):310-7. Available from: http://erj.ersjournals.com/content/37/2/310.long
20.Bonini M. Electronic health (e-Health): emerging role in asthma. Curr Opin Pulm Med.
2017 Jan;23(1):21-26. Available from:
https://insights.ovid.com/pubmed?pmid=27763999
21.Ambrosino N, Fracchia C. The role of tele-medicine in patients with respiratory diseases.
Expert Rev Respir Med. 2017 Nov;11(11):893-900. Available from:
https://www.tandfonline.com/doi/abs/10.1080/17476348.2017.1383898?journalCode
=ierx20
22. Hernandez C1, Mallow J2, Narsavage GL3. Delivering telemedicine interventions in
chronic respiratory disease. Breathe (Sheff). 2014 Sep;10(3):198-212. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734754/
23. Wootton R, Vladzymyrskyy A, Zolfo M, Bonnardot L. Experience with low-cost
telemedicine in three different settings. Recommendations based on a proposed
framework for network performance evaluation. Global Health Action 2011, 4: 7214.
Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234078/
24. Wootton R, Bonnardot L. In what circumstances is telemedicine appropriate in the
developing world? JRSM Short Rep. 2010 Oct 1;1(5):37. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984368/
25.Barbosa IA, Silva MJP. Cuidado de enfermagem por telessaúde: qual a influência da
distância na comunicação? Rev Bras Enferm. 2017;70(5):978-84. Disponível em:
http://www.scielo.br/pdf/reben/v70n5/pt_0034-7167-reben-70-05-0928.pdf | pt_BR |
dc.type.degree | Mestrado Acadêmico | pt_BR |
Aparece nas coleções: | Dissertação (PPGENF)
|